-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MasAOZseWvFUrmcLc/Gxk0hNRCAi4sbTCZsuAc4FGek9fs5npVVkF//jqfcwgkA9 /t/cU/Uso11opAhT9p8wJQ== 0001019687-08-004113.txt : 20080911 0001019687-08-004113.hdr.sgml : 20080911 20080911134838 ACCESSION NUMBER: 0001019687-08-004113 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080911 DATE AS OF CHANGE: 20080911 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGY RESEARCH GROUP INC CENTRAL INDEX KEY: 0001044119 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 133940486 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-78314 FILM NUMBER: 081066900 BUSINESS ADDRESS: STREET 1: 2300 NORTH LOOP ROAD, #300 CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 510-263-2000 MAIL ADDRESS: STREET 1: 2300 NORTH LOOP ROAD, #300 CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: SCOTTSDALE SCIENTIFIC INC DATE OF NAME CHANGE: 19990423 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LEVINE STEPHEN A CENTRAL INDEX KEY: 0001136469 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 30806 SANTANA STREET CITY: HAYWARD STATE: CA ZIP: 94544 FORMER COMPANY: FORMER CONFORMED NAME: LEVINE STEPHEN L DATE OF NAME CHANGE: 20010308 SC 13D/A 1 stephenlevine_13da2.txt SCHEDULE 13D AMENDMENT NO. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2)* Allergy Research Group, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.001 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 01849R - -------------------------------------------------------------------------------- (CUSIP Number) Dr. Stephen A. Levine, 15 Bridge Road, Kentfield, CA 94904 (415) 925-1751 - -------------------------------------------------------------------------------- Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) September ___, 2008 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. |_| NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 01849R Page 1 of 2 - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. Dr. Stephen A. Levine, for himself and as Trustee of The Levine Family Trust (UTD March 21, 1990, as amended), a revocable trust, and Trustee of the Stephen and Susan Levine TR, the Levine Children's TR (UTD March 27,1998), a irrevocable trust - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Source of Funds (See Instructions) Not applicable. - -------------------------------------------------------------------------------- 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6. Citizenship or Place of Organization USA - -------------------------------------------------------------------------------- Number of Shares 7. Sole Voting Power Beneficially Owned by None Each Reporting ---------------------------------------------------- Person With: 8. Shared Voting Power None ---------------------------------------------------- 9. Sole Dispositive Power None. ---------------------------------------------------- 10. Shared Dispositive Power None ---------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person None - -------------------------------------------------------------------------------- 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) |_| - -------------------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row (11) 0% - -------------------------------------------------------------------------------- 14. Type of Reporting Person (See Instructions) IN - -------------------------------------------------------------------------------- INTRODUCTION: Dr. Stephen A. Levine, for himself and as Trustee of The Levine Family Trust (UTD March 21, 1990, as amended), a revocable trust, and Trustee of the Stephen and Susan Levine TR, the Levine Children's TR (UTD March 27,1998), a irrevocable trust (the "Reporting Person"), is filing this Amendment No. 2 to Schedule 13D relating to Allergy Research Group, Inc. (the "Issuer") to disclose that he is no longer the beneficial owner of any shares of Common Stock of the Issuer. ITEM 4. PURPOSE OF TRANSACTION As previously disclosed, the Reporting Person sold all shares of Common Stock of which he or either trust was beneficial owner at a price of $1.33 per share in the tender offer by KI NutriCare, Inc., through its wholly owned subsidiary Longhorn Acquisition Corp. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER (a) Upon tendering all shares of Common Stock of which he or either trust was a beneficial owner to Longhorn Acquisition Corp., the Reporting Person no longer holds any shares of Common Stock of the Issuer. (c) The Reporting Person tendered all shares of Common Stock of which he or either trust was a beneficial owner to Longhorn Acquisition Corp. for $1.33 per share on August 18, 2008. (e) On August 18, 2008, the date on which the Reporting Person tendered all shares of Common Stock of which he or either trust was a beneficial owner to Longhorn Acquisition Corp., the Reporting Person ceased to be the beneficial owner of more than five percent of the Common Stock of the Issuer. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. September 9, 2008 - ----------------------- Date /s/ Stephen A. Levine - ----------------------- Stephen A. Levine, Ph.D. -----END PRIVACY-ENHANCED MESSAGE-----